Mesoblast (MESO) Current Assets (2015 - 2025)
Mesoblast (MESO) posted quarterly Current Assets of $202.5 million for Q4 2025, up 190.59% year-on-year from $69.7 million in Q4 2024, and down 0.91% on a QoQ basis from $204.4 million in Q2 2025.
Mesoblast (MESO) Current Assets (2015 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Current Assets for 11 consecutive years, with $202.5 million the latest figure, recorded in Q4 2025.
- Quarterly Current Assets rose 190.59% year-over-year to $202.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $202.5 million (up 190.59% YoY) and the FY2025 annual result came in at $204.4 million, up 136.34% from the prior year.
- Current Assets eased to $202.5 million in Q4 2025 per MESO's latest filing, from $204.4 million in the prior quarter.
- Over the last five years, Current Assets for MESO reached as high as $204.4 million in Q2 2025 and fell as low as $61.4 million in Q1 2023.
- A 5-year average of $111.5 million and a median of $88.1 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets sank 52.89% — and 2025, when it soared 190.59%.
- Year by year, Current Assets stood at $108.8 million in 2021, then fell by 28.18% to $78.1 million in 2022, then gained by 8.99% to $85.2 million in 2023, then slipped by 18.17% to $69.7 million in 2024, then jumped by 190.59% to $202.5 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $202.5 million, $204.4 million, and $69.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | 202.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 202.48 Mn |
| Jun 30, 2025 | 204.35 Mn |
| Dec 31, 2024 | 69.68 Mn |
| Jun 30, 2024 | 86.46 Mn |
| Dec 31, 2023 | 85.15 Mn |
| Jun 30, 2023 | 81.66 Mn |
| Mar 31, 2023 | 61.37 Mn |
| Dec 31, 2022 | 78.13 Mn |
| Sep 30, 2022 | 92.96 Mn |
| Jun 30, 2022 | 69.84 Mn |
| Mar 31, 2022 | 88.13 Mn |
| Dec 31, 2021 | 108.80 Mn |
| Sep 30, 2021 | 126.22 Mn |
| Jun 30, 2021 | 148.23 Mn |
| Mar 31, 2021 | 169.77 Mn |
| Dec 31, 2020 | 90.46 Mn |
| Sep 30, 2020 | 115.74 Mn |
| Jun 30, 2020 | 136.55 Mn |
| Mar 31, 2020 | 69.39 Mn |
| Dec 31, 2019 | 93.31 Mn |